Study demonstrates weak link to race disparity in lung cancer
Race does not affect overall survival among lung cancer patients, according to data presented at the 2010 AACR Conference on The Science of Cancer Health Disparities.
Lung Cancer
Loss of micro-RNA may trigger malignant growth in lung cancer cells
Micro-RNA plays an important role in the malignancy of lung cancer, according to a study published in Molecular Cancer Research (2010 Sep;8(9):1207-16).
Study reveals mechanism underlying decreased sensitivity to targeted lung cancer therapy
Researchers have discovered new mechanisms of resistance to targeted lung cancer, according to a study published in Proceedings of the National Academy of Sciences (2010 Aug 31;107(35):15535-40).
Estrogen use not associated with increased lung cancer risk
Postmenopausal women who use estrogen do not increase their risk for lung cancer mortality, according to a study published in The Journal of the National Cancer Institute (2010 Aug 13. [Epub ahead of print]).
Study defines follow-up standards for early-stage lung cancer
Long-term follow-up strategies can be defined for patients with early-stage lung cancer, according to a study published in the Journal of Thoracic Oncology (2010 Aug;5(8):1246-50).
Shortness of breath effects patients over the long-term after lung cancer treatment
Long-term lung cancer survivors suffer from dyspnea, according to a study published in the Journal of Thoracic Oncology (2010 Aug;5(8):1221-6).
Specific oncogene may serve as marker for lung squamous cell carcinoma
Researchers have identified an oncogene that is linked specifically to lung squamous cell carcinoma, according to a study published in PLoS Medicine (2010 Jul 27;7(7):e1000315).
Blood test may help diagnose lung cancer earlier
Genetically abnormal cells circulating in patients with non-small cell lung cancer may actually be tumor cells, according to a study published in the journal Clinical Cancer Research (2010 Jul 22. [Epub ahead of print]).
Doxorubicin
Doxorubicin is an anthracycline antibiotic that is used to treat lymphoblastic and acute myeloblastic leukemias, several types of cancer, Kaposi sarcoma related to AIDS, malignant lymphoma, soft tissue and osteogenic sarcomas, and Wilms tumor.
Non-small cell lung cancer therapy has mixed results
Targeted agents may improve outcomes for patients with advanced non-small cell lung cancer.
-
Loading...
-
Loading...
